THE MASCC TEXTBOOK OF CANCER SUPPORTIVE CARE AND SURVIVORSHIP. 2ND EDITION

THE MASCC TEXTBOOK OF CANCER SUPPORTIVE CARE AND SURVIVORSHIP. 2ND EDITION

Editorial:
SPRINGER
Año de edición:
Materia
Oncología
ISBN:
978-3-319-90989-9
Páginas:
750
N. de edición:
2
Idioma:
Inglés
Ilustraciones:
66
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

145,60 €

Despues:

138,32 €

This book is intended for medical students, residents, and fellows, as well as medical oncologists, radiation oncologists, surgeons, general practitioners, nurses and allied health workers. Complete with case vignettes, key points, and sidebar summaries to further assist readers using practical tips and tricks, this textbook provides current information on the management and prevention of cancer-related side effects, referring to up-to-date sources that are useful for conducting further research. It also introduces new topics, such as financial toxicity and complementary medicine, as well as covering the new side effects of targeted therapies not covered in the last edition. Additionally, MASCC Textbook of Cancer Supportive Care and Survivorship, 2nd edition assembles international, multidisciplinary experts who focus on a comprehensive range of symptoms and side effects associated with cancer and its treatment.
Over the last five years, much progress has been made in supportive care, helping people cope with the symptoms of cancer and cancer treatment and addressing the physical and psychosocial matters of survivorship prior to, during, and after anticancer treatment. This is central to a patient’s wellbeing and the MASCC Textbook of Cancer Supportive Care and Survivorship, 2nd edition, explores not only the diagnosis and treatment, but also the increasingly recognized complex and ongoing symptoms experienced by long term cancer survivors. Significant advances have been made, designing strategies to manage the side effects and symptoms of treatment and to prevent them from occurring, maximizing the person’s ability to pursue daily activities.

Features
• Updated new edition introduces topics such as financial toxicity and complementary medicine
• Discusses the new side effects of targeted therapies
• Assembles international, multidisciplinary experts who focus on a comprehensive range of symptoms and side effects associated with cancer and its treatment
• Includes case vignettes, key points, and sidebar summaries to further assist readers using practical tips and tricks
• Written by internationally recognized experts for med students, residents, and fellows, as well as medical oncologists, radiation oncologists, surgeons, general practitioners, nurses and allied health workers
• Provides current information on the management and prevention of cancer related side effects, referring to up-to-date sources that are useful for conducting further research

Author
Ian Olver, MD, PhD is CEO, Cancer Council Australia, a Clinical Professor in the Department of Medicine at the University of Sydney and is an Honorary Associate, Department of Medical Oncology, Royal Prince Alfred Hospital. He has published over 180 articles in journals, 16 book chapters and 2 books: Conquering Cancer. Your Guide to Treatment and Research, and Is Death Ever Preferable to Life? and co-edited When Cancer Crosses Disciplines: A Physicians Handbook. After serving on several ethics committees in Victoria and South Australia and the American Society of Clinical Oncology (ASCO) Ethics Committee, and chairing the Cancer Institute NSW Research Ethics Committee for multi-centre cancer trials, he now sits on the Australian Health Ethics Committee of the NHMRC and chairs the Medical Oncology Group of Australia Ethics Committee. He previously served on The Australian Drug Evaluation Committee (ADEC) and the Cancer Strategies Group of the Australian Government and chaired the Medical Oncology Group of Australia (MOGA). He now serves on the Board of the National Breast and Ovarian Cancer Centre, the executive of the Clinical Oncological Society of Australia and the Advisory Board of Cancer Australia and the Community and Preventative Health Committee of NH+MRC.